Nuwellis (NUWE) EBIT Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,196.00 |
| Dec 31, 2025 | -56,160.00 |
| Sep 30, 2025 | 10,193.00 |
| Jun 30, 2025 | 4,195.00 |
| Mar 31, 2025 | 11,947.00 |
| Dec 31, 2024 | 22,244.00 |
| Sep 30, 2024 | 29,526.00 |
| Jun 30, 2024 | 15,830.00 |
| Mar 31, 2024 | 13,315.00 |
| Dec 31, 2023 | 14,288.00 |
| Sep 30, 2023 | 18,063.00 |
| Jun 30, 2023 | 13,823.00 |
| Mar 31, 2023 | 9,944.00 |
| Dec 31, 2022 | 126,941.00 |
| Sep 30, 2022 | 10,933.00 |
| Jun 30, 2022 | 9,488.00 |
| Mar 31, 2022 | 2,688.00 |
| Dec 31, 2021 | -123,039.00 |
| Sep 30, 2021 | 46,469.00 |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | -617,100.00 |
| Sep 30, 2019 | 999,595.00 |
| Mar 31, 2019 | 1.04 Mn |
| Sep 30, 2018 | 1.02 Mn |